CytoDyn Appoints Jacob Lalezari M.D. as Interim CEO

Nov 21, 2023 8:30am EST

November 2023 Letter to Shareholders

Nov 03, 2023 4:02pm EDT

CytoDyn Announces Company Updates and Investment Community Update Webcast

Jul 11, 2023 4:05pm EDT

CytoDyn Announces President Takes Medical Leave of Absence

May 24, 2023 5:05pm EDT

CytoDyn to Hold Webcast to Provide a Company Update

Apr 05, 2023 8:30am EDT

CytoDyn to Hold Webcast to Discuss the Performance of Leronlimab in Clinical Trials and Recent Charges Against Former CEO

Dec 23, 2022 8:00am EST

CytoDyn to Host R&D Update on Wednesday, December 7, 2022

Nov 22, 2022 8:30am EST

CytoDyn Announces Voluntary Withdrawal of BLA for HIV-MDR Due to CRO Data Management Issues

Oct 28, 2022 5:15pm EDT

CytoDyn Announces Appointment of Additional Directors with Industry Experience

Oct 20, 2022 8:30am EDT

CytoDyn to Hold Webcast to Provide a Quarterly Company Update

Sep 19, 2022 8:30am EDT